NewTimeSpace News: Aspial Lifestyle announced on May 25 that it has privately placed 149.254 million shares at SGD 0.402 apiece, with subscription volume exceeding twice the offering size. The placed shares will be listed and traded on the main board of Singapore Exchange on May 25, 2026.
China's AI industry has been experiencing a comprehensive resonance extending from macro policies to micro financial data. Weighty documents from the State Council made it clear that artificial intelligence legislation is accelerating, the National Development and Reform Commission (NDRC) is planning to issue supporting documents for "AI+", ByteDance has increased its AI capital expenditure, and both Zhipu and MiniMax have been included in the Hang Seng Tech Index. Following the NDRC press conference on May 22, Hong Kong-listed AI concept stocks shot up in a straight line. Zhipu (2513.HK) once surged over 30%, hitting another historical high, while MINIMAX (0100.HK), Mininglamp Technology-W (2718.HK), and Xunce (3317.HK) all rallied strongly.
NewTimeSpace News，DT CAPITAL (00356.HK) plans to issue in total 285.7 million shares by subscription, with estimated net proceeds of HKD 13.9 million.
Recently, enterprises related to large language models have entered a period of intensive product releases. A multi-polar, multi-functional application landscape is unfolding across the board.Catalyzed by industry and company news, stocks related to the large model concept have performed well this week. As of the market close on May 22, Zhipu saw a weekly gain of over 20%, Mininglamp Technology-W rose over 10% for the week, and stocks such as MINIMAX and Xunce experienced significant rebounds on May 22.
NewTimeSpace News: Hangzhou Diagens Biotechnology Co., Ltd. (02526.HK) announced that its core product AI AutoVision® was granted the Class III Medical Device Registration Certificate by the National Medical Products Administration (NMPA) on May 20, 2026. The approved indications cover chromosome karyotype analysis for prenatal diagnosis of birth defects using amniotic fluid samples, and chromosome karyotype analysis for assisted reproductive technology using peripheral blood samples. This is the world's first Class III medical device registration certificate for chromosome karyotype analysis with anomaly recognition capability at Level 3 (L3) autonomy, and also the first medical device registration certificate based on large model technology.
NewTimeSpace News: May 21, 2026, TONGCHENGTRAVEL(00780.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 5.01 billion, increased by 14.35% YoY
NewTimeSpace News: MoneyMax announced on May 21 that its wholly-owned subsidiary MoneyMax Treasure has issued S$30 million 5.00% fixed rate notes. These notes will be consolidated with its previously issued S$100 million similar notes into one series, and are expected to be listed on the Singapore Exchange on May 22, 2026.
NewTimeSpace News: Envictus International announced on May 21 that in accordance with the terms of the sale and purchase agreement, the company has fully settled the remaining 90% of the acquisition consideration to the seller, completing the takeover of the factory and warehouse located in Selangor, Malaysia.
By the close of trading on May 20, 2026, HESAI-W(02525.HK) saw a loss of 9.01% in its share price, closing at HKD 158.5. During the session, it reached an intraday high of HKD 161 and touched an intraday low of HKD 155.4.
NewTimeSpace News, HUANXI MEDIA (01003.HK) plans to issue in total 731.29 million shares by subscription, with estimated net proceeds of HKD 200.3 million.
NewTimeSpace News, CHINA BAOLI TEC (00164.HK) plans to issue in total 19.77 million shares by subscription, with estimated net proceeds of HKD 8 million.
NewTimeSpace News, By the close of trading on May 19, 2026, BRAINAURORA-B(06681.HK) saw a gain of 34.43% in its share price, closing at HKD 4.1. During the session, it reached an intraday high of HKD 4.75 and touched an intraday low of HKD 3.45.
NewTimeSpace News: XIAOMI-W(01810.HK) will spend HKD 100 million to repurchase 3.27 million shares on May 18, 2026.
NewTimeSpace News, as of 13:44 on May 18, 2026, E Fund Innovative Drug ETF (516080) fell 1.89%, with its latest quoted price at 0.62 yuan.Regarding scale, E Fund Innovative Drug ETF's AUM increased by 26.3388 million yuan over the past week, achieving significant growth, with the new scale increment ranking 1/7 among comparable funds.In terms of share size, the latest share count of E Fund Innovative Drug ETF reached 2.510 billion units, hitting a one-year high and ranking 3/7 among comparable funds.
NewTimeSpace News: May 15, 2026, INFINITY DEV(00640.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at HKD 401.54 million, decreased by 1.9% YoY
NewTimeSpace News: Hbm Holdings Limited (02142.HK) announced preclinical research findings of LET003, its next-generation ACVR2A/2B-targeted monoclonal antibody developed via the Hu-mAtrIx™ AI platform. Data revealed that combination therapy of LET003 and semaglutide delivers markedly enhanced fat reduction and effective lean mass preservation. The combined group achieved a 34.7% greater reduction in fat mass and a 5.7% rise in lean mass compared with semaglutide monotherapy.
